Cargando…

No elevated risk of COVID-19 in atopic dermatitis patients: a meta-analysis and trial sequential analysis

Detalles Bibliográficos
Autores principales: Zhou, Boyang, Shang, Shuai, Liang, Surong, Xiang, Lujing, Zhou, Kefei, Wu, Suhua, Li, Linfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646709/
https://www.ncbi.nlm.nih.gov/pubmed/38028420
http://dx.doi.org/10.5114/ada.2023.130543
_version_ 1785134944138297344
author Zhou, Boyang
Shang, Shuai
Liang, Surong
Xiang, Lujing
Zhou, Kefei
Wu, Suhua
Li, Linfeng
author_facet Zhou, Boyang
Shang, Shuai
Liang, Surong
Xiang, Lujing
Zhou, Kefei
Wu, Suhua
Li, Linfeng
author_sort Zhou, Boyang
collection PubMed
description
format Online
Article
Text
id pubmed-10646709
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-106467092023-10-01 No elevated risk of COVID-19 in atopic dermatitis patients: a meta-analysis and trial sequential analysis Zhou, Boyang Shang, Shuai Liang, Surong Xiang, Lujing Zhou, Kefei Wu, Suhua Li, Linfeng Postepy Dermatol Alergol Letter to the Editor Termedia Publishing House 2023-11-09 2023-10 /pmc/articles/PMC10646709/ /pubmed/38028420 http://dx.doi.org/10.5114/ada.2023.130543 Text en Copyright: © 2023 Termedia Sp. z o. o. https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Letter to the Editor
Zhou, Boyang
Shang, Shuai
Liang, Surong
Xiang, Lujing
Zhou, Kefei
Wu, Suhua
Li, Linfeng
No elevated risk of COVID-19 in atopic dermatitis patients: a meta-analysis and trial sequential analysis
title No elevated risk of COVID-19 in atopic dermatitis patients: a meta-analysis and trial sequential analysis
title_full No elevated risk of COVID-19 in atopic dermatitis patients: a meta-analysis and trial sequential analysis
title_fullStr No elevated risk of COVID-19 in atopic dermatitis patients: a meta-analysis and trial sequential analysis
title_full_unstemmed No elevated risk of COVID-19 in atopic dermatitis patients: a meta-analysis and trial sequential analysis
title_short No elevated risk of COVID-19 in atopic dermatitis patients: a meta-analysis and trial sequential analysis
title_sort no elevated risk of covid-19 in atopic dermatitis patients: a meta-analysis and trial sequential analysis
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646709/
https://www.ncbi.nlm.nih.gov/pubmed/38028420
http://dx.doi.org/10.5114/ada.2023.130543
work_keys_str_mv AT zhouboyang noelevatedriskofcovid19inatopicdermatitispatientsametaanalysisandtrialsequentialanalysis
AT shangshuai noelevatedriskofcovid19inatopicdermatitispatientsametaanalysisandtrialsequentialanalysis
AT liangsurong noelevatedriskofcovid19inatopicdermatitispatientsametaanalysisandtrialsequentialanalysis
AT xianglujing noelevatedriskofcovid19inatopicdermatitispatientsametaanalysisandtrialsequentialanalysis
AT zhoukefei noelevatedriskofcovid19inatopicdermatitispatientsametaanalysisandtrialsequentialanalysis
AT wusuhua noelevatedriskofcovid19inatopicdermatitispatientsametaanalysisandtrialsequentialanalysis
AT lilinfeng noelevatedriskofcovid19inatopicdermatitispatientsametaanalysisandtrialsequentialanalysis